Cargando…
Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vacci...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750013/ https://www.ncbi.nlm.nih.gov/pubmed/36516143 http://dx.doi.org/10.1371/journal.pone.0278337 |
_version_ | 1784850156201443328 |
---|---|
author | Geissler, Ferdinand Hartmann, Felix Humphreys, Macartan Klüver, Heike Giesecke, Johannes |
author_facet | Geissler, Ferdinand Hartmann, Felix Humphreys, Macartan Klüver, Heike Giesecke, Johannes |
author_sort | Geissler, Ferdinand |
collection | PubMed |
description | By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vaccination rates. Given that governments need to secure public support for investments in global vaccine sharing, it is important to understand the levels and drivers of public support for international vaccine solidarity. Using a factorial experiment administered to more than 10,000 online survey respondents in Germany in 2021, we demonstrate that the majority of German citizens are against global inequalities in vaccine distribution. Respondents are supportive of substantive funding amounts, on the order of the most generous contributions provided to date, though still below amounts that are likely needed for a successful global campaign. Public preferences appear largely to be driven by intrinsic concern for the welfare of global populations though are in part explained by material considerations—particularly risks of continued health threats from a failure to vaccinate globally. Strategic considerations are of more limited importance in shaping public opinion; in particular we see no evidence for free riding on contributions by other states. Finally, drawing on an additional survey experiment, we show that there is scope to use information campaigns highlighting international health externalities to augment public support for global campaigns. |
format | Online Article Text |
id | pubmed-9750013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97500132022-12-15 Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany Geissler, Ferdinand Hartmann, Felix Humphreys, Macartan Klüver, Heike Giesecke, Johannes PLoS One Research Article By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vaccination rates. Given that governments need to secure public support for investments in global vaccine sharing, it is important to understand the levels and drivers of public support for international vaccine solidarity. Using a factorial experiment administered to more than 10,000 online survey respondents in Germany in 2021, we demonstrate that the majority of German citizens are against global inequalities in vaccine distribution. Respondents are supportive of substantive funding amounts, on the order of the most generous contributions provided to date, though still below amounts that are likely needed for a successful global campaign. Public preferences appear largely to be driven by intrinsic concern for the welfare of global populations though are in part explained by material considerations—particularly risks of continued health threats from a failure to vaccinate globally. Strategic considerations are of more limited importance in shaping public opinion; in particular we see no evidence for free riding on contributions by other states. Finally, drawing on an additional survey experiment, we show that there is scope to use information campaigns highlighting international health externalities to augment public support for global campaigns. Public Library of Science 2022-12-14 /pmc/articles/PMC9750013/ /pubmed/36516143 http://dx.doi.org/10.1371/journal.pone.0278337 Text en © 2022 Geissler et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Geissler, Ferdinand Hartmann, Felix Humphreys, Macartan Klüver, Heike Giesecke, Johannes Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title | Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title_full | Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title_fullStr | Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title_full_unstemmed | Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title_short | Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany |
title_sort | public support for global vaccine sharing in the covid-19 pandemic: evidence from germany |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750013/ https://www.ncbi.nlm.nih.gov/pubmed/36516143 http://dx.doi.org/10.1371/journal.pone.0278337 |
work_keys_str_mv | AT geisslerferdinand publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany AT hartmannfelix publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany AT humphreysmacartan publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany AT kluverheike publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany AT gieseckejohannes publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany |